HCA Healthcare, Inc. $HCA Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 433,141 shares of the company’s stock after acquiring an additional 4,421 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in HCA Healthcare were worth $165,936,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Park Place Capital Corp increased its stake in HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock worth $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after acquiring an additional 2,698 shares during the last quarter. Harrell Investment Partners LLC boosted its position in shares of HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after buying an additional 1,158 shares during the period. Brown Advisory Inc. boosted its position in shares of HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after buying an additional 1,622 shares during the period. Finally, Oppenheimer Asset Management Inc. boosted its holdings in HCA Healthcare by 2.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after purchasing an additional 105 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on HCA shares. Barclays lifted their target price on HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a report on Thursday, September 18th. Truist Financial set a $460.00 price target on HCA Healthcare in a report on Tuesday, October 14th. UBS Group lifted their price target on HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $444.00 price target on shares of HCA Healthcare in a report on Tuesday, October 7th. Finally, Wells Fargo & Company boosted their target price on HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $437.19.

HCA Healthcare Stock Up 1.5%

Shares of HCA stock opened at $446.58 on Friday. The stock has a market capitalization of $104.50 billion, a PE ratio of 18.77, a price-to-earnings-growth ratio of 1.39 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $461.56. The stock’s 50-day moving average price is $414.84 and its 200 day moving average price is $381.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same quarter in the previous year, the firm posted $4.90 EPS. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 12.11%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.